<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(5)</volume><submitter>Biswas I</submitter><pubmed_abstract>&lt;h4>Abstract&lt;/h4>Antithrombin (AT) is an anticoagulant serpin involved in the regulation of proteolytic activities of coagulation proteases. AT also possesses a direct anti-inflammatory function. The anticoagulant function of AT is mediated through its reactive center loop-dependent inhibition of coagulation proteases, but anti-inflammatory function of AT is mediated via its D-helix-dependent interaction with vascular glycosaminoglycans (GAGs). In vitro assays have established that therapeutic heparins promote the anticoagulant function of AT by binding D-helix and activating the serpin, however, the contribution of vascular GAGs to D-helix-dependent anticoagulant function of AT has remained poorly understood in vivo. Here, we explored this question by using 2 AT mutants, (AT-4Mut), which </pubmed_abstract><journal>Blood advances</journal><pagination>966-978</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11907474</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Physiological significance of antithrombin D-helix interaction with vascular GAGs.</pubmed_title><pmcid>PMC11907474</pmcid><pubmed_authors>Lupu F</pubmed_authors><pubmed_authors>Biswas I</pubmed_authors><pubmed_authors>Rezaie AR</pubmed_authors><pubmed_authors>Panicker SR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Physiological significance of antithrombin D-helix interaction with vascular GAGs.</name><description>&lt;h4>Abstract&lt;/h4>Antithrombin (AT) is an anticoagulant serpin involved in the regulation of proteolytic activities of coagulation proteases. AT also possesses a direct anti-inflammatory function. The anticoagulant function of AT is mediated through its reactive center loop-dependent inhibition of coagulation proteases, but anti-inflammatory function of AT is mediated via its D-helix-dependent interaction with vascular glycosaminoglycans (GAGs). In vitro assays have established that therapeutic heparins promote the anticoagulant function of AT by binding D-helix and activating the serpin, however, the contribution of vascular GAGs to D-helix-dependent anticoagulant function of AT has remained poorly understood in vivo. Here, we explored this question by using 2 AT mutants, (AT-4Mut), which </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2025-04-05T22:06:03.221Z</modification><creation>2025-04-05T22:06:03.221Z</creation></dates><accession>S-EPMC11907474</accession><cross_references><pubmed>39671300</pubmed><doi>10.1182/bloodadvances.2024014756</doi></cross_references></HashMap>